A simple, reliable and safe diagnostic device for preterm birth prevention

Project description

A device for predicting the risk of preterm birth

Babies born before 37 weeks of gestation are considered premature and have an elevated risk of short- and long-term medical complications including death. Common causes of preterm birth include maternal conditions such as diabetes and high blood pressure. Early detection is difficult because symptoms are mild and resemble those occurring in normal pregnancies. To address this problem, the EU-funded Pregnolia project has developed an innovative device that determines the stiffness of the cervical tissue as an indicator of preterm birth risk. The device is safe and easy to use, offering twice the sensitivity of ultrasound, which has been the gold standard for preterm birth detection.

Fields of science

• social sciences › sociology › demography › mortality
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs
• natural sciences › biological sciences › biochemistry › biomolecules › proteins
• medical and health sciences › clinical medicine › obstetrics
• natural sciences › physical sciences › acoustics › ultrasound

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

PREGNOLIA AG

Net EU contribution

€ 50 000,00

Address

Wiesenstrasse 33
8952 Schlieren
Switzerland

Region

Schweiz/Suisse/Svizzera › Zürich › Zürich

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Other funding

€ 21 429,00